I. Neaman

Multicenter evaluation of the Bayer Immuno I CA 15-3 assay.

D. Chan, A. Wu, W. J. Allard, 1998, Clinical chemistry.

Nonspecific cross-reacting antigen 50/90 is elevated in patients with breast, lung, and colon cancer.

W. J. Allard, J. Elting, H. Yoshimura, 1994, Cancer research.

Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer.

D. Chan, A. Partin, L. Sokoll, 2000, The Journal of urology.

Clinical utility of serum HER-2/neu testing on the Bayer Immuno 1 automated system in breast cancer.

D. Chan, W. J. Allard, M. Schwartz, 2001, Anticancer research.

Measurement of four tumor marker antigens in the sera of pregnant women

W. J. Allard, K. Yeung, C. Cheli, 1999, Journal of clinical laboratory analysis.